July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Long-term Low-dose Aspirin Exacerbates Laser-induced Choroidal Neovascularization Through Down-regulating Thrombospondin-1 Expression
Author Affiliations & Notes
  • Chang Luo
    Aier Eye Institute, Aier Eye Hospital Group, Changsha, Hunan, China
  • Mei Chen
    Centre for Experimental Medicine, School of Medicine, Dentistry & Biological Sciences, Queen’s University Belfast, Belfast, United Kingdom
  • Rosana G. Penalva
    Centre for Experimental Medicine, School of Medicine, Dentistry & Biological Sciences, Queen’s University Belfast, Belfast, United Kingdom
  • Jiawu Zhao
    Centre for Experimental Medicine, School of Medicine, Dentistry & Biological Sciences, Queen’s University Belfast, Belfast, United Kingdom
  • Jiansu Chen
    Aier Eye Institute, Aier Eye Hospital Group, Changsha, Hunan, China
  • Shibo Tang
    Aier Eye Institute, Aier Eye Hospital Group, Changsha, Hunan, China
  • Heping Xu
    Aier Eye Institute, Aier Eye Hospital Group, Changsha, Hunan, China
    Centre for Experimental Medicine, School of Medicine, Dentistry & Biological Sciences, Queen’s University Belfast, Belfast, United Kingdom
  • Footnotes
    Commercial Relationships   Chang Luo, None; Mei Chen, None; Rosana Penalva, None; Jiawu Zhao, None; Jiansu Chen, None; Shibo Tang, None; Heping Xu, None
  • Footnotes
    Support  Fight for Sight (Ref. 1361/62), National Natural Science Foundation of China (Ref. 81700827).
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5557. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chang Luo, Mei Chen, Rosana G. Penalva, Jiawu Zhao, Jiansu Chen, Shibo Tang, Heping Xu; Long-term Low-dose Aspirin Exacerbates Laser-induced Choroidal Neovascularization Through Down-regulating Thrombospondin-1 Expression. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5557.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Recent evidence suggests that long-term, low-dose aspirin intake increases the risk of neovascular age-related macular degeneration (nAMD) although the underlying mechanism remains poorly defined. This study investigated the role of long-term, low-dose aspirin intake in mouse model of laser-induced choroidal neovascularization (CNV).

Methods : Young (3-month old) and old C57BL/6J mice (16-month old) received daily oral administration of 0.04 mg/mouse aspirin for 8 weeks followed by CNV induction. Aspirin treatment continued for another week before mice were sacrificed for sample collection. Eyes were collected for immunohistochemistry. Flow cytometry was conducted in blood samples using antibodies against CD4, CD8, CD11b, Gr1, B220, LFA1, ICAM1 and MHCII. Bone marrow-derived macrophages (BMDMs, defined as M0) were polarized to M1 (LPS+IFN-γ) or M2 (IL-4) with or without aspirin (1~100uM). Gene expression levels of cytokine and angiogenic factors were evaluated by real-time PCR.

Results : Aged mice developed more severe CNV compared with young mice. Aspirin treatment significantly increased the size of CNV in both young and aged mice, and the increment was more pronounced in young mice. The population of CD11b, Gr1 and MHCII+ cells was increased following CNV induction. Aspirin treatment did not significantly affect immune cell constitution. LPS+IFN-γ treatment significantly increased the expression of TNF-α, IL-1β, CCL2, IL-6, and thrombospondin-1 (TSP-I). Aspirin treatment significantly suppressed LPS+IFN-γ-induced upregulation of IL-1β. The treatment totally prevented LPS+IFN-γ-induced upregulation of TSP-1. VEGF expression in BMDMs was not affected by aspirin treatment.

Conclusions : TSP-1 is an anti-angiogenic growth factor that is known to play an important role in retinal homeostasis. Our results suggest that long-term, low-dose aspirin intake may increase the risk of nAMD by suppressing TSP-1 production.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×